Back to results
US 2020/0368185 A1Published application
Combination formulation containing sustained release metformin and immediate release hmg-coa reductase inhibitor
AssigneeHk Inno.N Corporation
InventorsKwi Man KANG, Young Joon PARK, Jun Hong PARK, Ji Eun LEE, Seok Kee YOON, Yu Jeong KIM, Tack Oon OH, Tae Keun CHO
Life of this patent
Estimating the term…
Abstract
The present invention relates to a combination formulation containing metformin for treating non-insulin-dependent diabetes and an HMG-CoA reductase inhibitor for treating dyslipidemia. The present invention provides a combination formulation and a method for preparing the combination formulation, wherein the combination formulation contains metformin and an HMG-CoA reductase inhibitor.
Claims16
A combination formulation comprising:
- a first sustained-release composition, which comprises granules comprising metformin or a pharmaceutically acceptable salt thereof and a swellable polymer, and a water-insoluble polymer film for coating the granules;
- and
- a second immediate-release composition comprising an HMG-CoA reductase inhibitor.
Dependencies are inferred from the claim text.